SOURCE: Market Pulse

April 19, 2005 09:15 ET

Market Pulse News Alert for Tuesday, April 19, 2005: BIPH - Biophan CEO Michael Weiner to Provide Expert Commentary at World Nano-Economic Congress Ireland in Dublin!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- April 19, 2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Biophan Technologies, Inc. (OTC BB: BIPH), Neurochem, Inc. (NASDAQ: NRMX), Adobe Systems Inc. (NASDAQ: ADBE), and Dell Inc. (NASDAQ: DELL).

Investors need to be watching Biophan Technologies, Inc. (OTC BB: BIPH) this AM! Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. Biophan's technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. BIPH had excellent news out in a press release before today's opening bell regarding their CEO Michael Weiner will attend the World Nano-Economic Congress in Dublin, Ireland where he will deliver a presentation! Investors should be watching this one closely!

Biophan Technologies, Inc. (OTC BB: BIPH), a developer of next-generation biomedical technology, has announced that CEO Michael Weiner will attend the World Nano-Economic Congress in Dublin, Ireland, where he will deliver a presentation on the topic of "Nanotechnology for Medical Devices and Biomaterial Applications." In a separate event, Mr. Weiner will also sit on an expert panel, before a gathering of industry and scientific leaders from around the world, to discuss how the applications of nanotechnology within the medical and pharmaceutical industry will transform healthcare in the future. The conference will be held April 20-21.

The World Nano-Economic Congress (WNEC) events have established themselves as comprehensive meetings bringing together leaders in science, government, and business to discuss the promise and commercial development of nanotechnology.

During the panel discussion, scheduled for April 20, Mr. Weiner will join other nanotechnology industry leaders to discuss ways in which nanotechnology applications in the medical and pharmaceutical industries may transform and improve healthcare. Biophan's research and development programs are leveraging the Company's extensive intellectual property portfolio in nanotechnology to develop applications in a range of multi-billion-dollar healthcare marketplaces.

In addition to his participation on the panel, Mr. Weiner is scheduled to deliver an individual presentation about emerging nanotechnology applications in the medical device and biomaterials industry. He will discuss Biophan's proprietary nanotechnology applications and its extensive intellectual property portfolio. Biophan's product and technology initiatives include thin-film nanomagnetic coatings that make pacemakers, vascular stents, and other medical devices safe and imageable within Magnetic Resonance Imaging (MRI) environments. The Company is also developing cutting-edge nanotechnology applications in areas such as next-generation implantable biothermal batteries that can use body heat to power medical devices for decades without replacement, and to engineer advanced implantable drug-elution functionality for the $40 billion drug-delivery marketplace.

About The World Nano-Economic Congress Ireland

The World Nano-Economic Congress Ireland is a cooperative effort between Cientifica and the Irish Nanotechnology Association to bring the focus of nanotechnology and its impact upon industries to the rapidly growing economy of Ireland. The WNEC Ireland is an extension of The World Nano-Economic Congress series of events that have been held since 2003 in every major region of the world, including Washington, D.C., London, Munich, and Singapore. WNEC Ireland is the fifth event in this international series of conferences. For more information on the World Nano-Economic Forum, please visit www.world-nano.com.

About Biophan Technologies

Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers and interventional surgical devices such as catheters, guidewires, stents, and other implants to allow them to be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 114 U.S. patents, licenses, or applications. This total includes 36 issued U.S. patents, 6 recently-allowed applications that will issue as patents in the near future, and 72 pending applications at various stages of examination at the U.S. Patent and Trademark Office, plus international applications. The patents cover areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life. For more information, please visit www.biophan.com.

Stocks that ended the day down in yesterday's trading include: Neurochem, Inc. (NASDAQ: NRMX), Adobe Systems Inc. (NASDAQ: ADBE), and Dell Inc. (NASDAQ: DELL).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated one hundred thousand dollars from Biophan Technologies, Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.

Contact Information